
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Endocrinol. , 09 May 2022
Sec. Clinical Diabetes
Volume 13 - 2022 | https://doi.org/10.3389/fendo.2022.916377
This article is a correction to:
Effectiveness of Remotely Delivered Interventions to Simultaneously Optimize Management of Hypertension, Hyperglycemia and Dyslipidemia in People With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
By Fernando ME, Seng L, Drovandi A, Crowley BJ and Golledge J (2022) Front. Endocrinol. 13:848695. doi: 10.3389/fendo.2022.848695
In the original article, there were mistakes in Figure 2B, Figure 2C, Figure 3A and Figure 3B as published. The corrected Figures 2 and 3 appear here.
Figure 2 (A) Forest plot showing the effect of remote risk factor management on HbA1c, (B) Forest plot showing the effect of remote management on total cholesterol, (C) Forest plot showing the effect of remote risk factor management on LDL-cholesterol.
Figure 3 (A) Forest plot showing the effect of remote management on systolic blood pressure, (B) Forest plot showing the effect of remote risk factor management on diastolic blood pressure.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: blood pressure, cholesterol, lipids, systematic review, telehealth
Citation: Fernando ME, Seng L, Drovandi A, Crowley BJ and Golledge J (2022) Corrigendum: Effectiveness of Remotely Delivered Interventions to Simultaneously Optimize Management of Hypertension, Hyperglycemia and Dyslipidemia in People With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front. Endocrinol. 13:916377. doi: 10.3389/fendo.2022.916377
Received: 09 April 2022; Accepted: 19 April 2022;
Published: 09 May 2022.
Edited and reviewed by:
Fariba Ahmadizar, University Medical Center Utrecht, NetherlandsCopyright © 2022 Fernando, Seng, Drovandi, Crowley and Golledge. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jonathan Golledge, Sm9uYXRoYW4uR29sbGVkZ2VAamN1LmVkdS5hdQ==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.